Literature DB >> 23241105

Left ventricular ejection fraction and left ventricular end-diastolic volume in patients with diastolic dysfunction.

Ion S Jovin1, Keita Ebisu, Yi-Hwa Liu, Laurie A Finta, Adriana D Oprea, Cynthia A Brandt, James Dziura, Frans J Wackers.   

Abstract

Diastolic dysfunction can be diagnosed on equilibrium radionuclide angiocardiography (ERNA) by a low peak filling rate (PFR) in the setting of a normal left ventricular ejection fraction (LVEF). The authors evaluated the relationship between diastolic dysfunction, LVEF, and end-diastolic volume (EDV). A total of 408 predominantly asymptomatic patients with an LVEF ≥50% by ERNA were studied. LVEF of patients with a low PFR was compared with the LVEF of patients with a normal PFR. Correlation analyses to evaluate the association between PFR and EDV were also performed. The LVEF of patients with a low PFR was lower than the LVEF of patients with normal PFR (59±7 vs 63%±7%; P<.01). There was no correlation between EDV and PFR (r=-0.04; P=.32). The results did not change when the EDV indices were used. In patients who had repeat scans, there was no correlation between the change in EDV and the change in PFR (r=0.16; P=.2). In asymptomatic patients undergoing ERNA who have normal systolic function, a low PFR can be associated with a lower LVEF, but it is not associated with changes in EDV. This suggests that diastolic dysfunction is associated with mild systolic dysfunction.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23241105     DOI: 10.1111/chf.12013

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  3 in total

1.  Increased long-term mortality in women with high left ventricular ejection fraction: data from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter) long-term registry.

Authors:  Catherine Gebhard; Monika Maredziak; Michael Messerli; Ronny R Buechel; Fay Lin; Heidi Gransar; Stephan Achenbach; Mouaz H Al-Mallah; Daniele Andreini; Jeroen J Bax; Daniel S Berman; Matthew J Budoff; Filippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Kavitha Chinnaiyan; Benjamin J W Chow; Ricardo C Cury; Augustin DeLago; Gudrun Feuchtner; Martin Hadamitzky; Joerg Hausleiter; Yong-Jin Kim; Jonathon Leipsic; Erica Maffei; Hugo Marques; Pedro de Araújo Gonçalves; Gianluca Pontone; Gilbert L Raff; Ronen Rubinshtein; Leslee J Shaw; Todd C Villines; Yao Lu; Erica C Jones; Jessica M Peña; James K Min; Philipp A Kaufmann
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-04-01       Impact factor: 6.875

2.  Abdominal obesity and hypertension: a double burden to the heart.

Authors:  Paweł Krzesiński; Adam Stańczyk; Katarzyna Piotrowicz; Grzegorz Gielerak; Beata Uziębło-Zyczkowska; Andrzej Skrobowski
Journal:  Hypertens Res       Date:  2016-01-21       Impact factor: 3.872

3.  Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA).

Authors:  E J Reuvekamp; B F Bulten; A A Nieuwenhuis; M R A Meekes; A F J de Haan; J Tol; A H E M Maas; S E Elias-Smale; L F de Geus-Oei
Journal:  J Nucl Cardiol       Date:  2015-06-06       Impact factor: 5.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.